The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2024-10-24
DOI
https://doi.org/10.1186/s12885-024-13064-1
Citations
4
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
1.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer

Ezgi Değerli, G. Sen, Murad Guliyev, Nebi Serkan Demirci et al.
4 citations
BMC Cancer
HER2/EGFR in Cancer Research
1.13
article

The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer

Ezgi Değerli, G. Sen, Murad Guliyev, Nebi Serkan Demirci, Nihan Şentürk Öztaş, Esra Aydın, Hande Turna, Fuat Demirelli
article en
4 citations

Abstract

No abstract available for this paper.
BMC CancerVol. 24(1)
Recep Tayyip Erdoğan University (TR), Istanbul University-Cerrahpaşa (TR)
Good health and well-being
Openalex Percentile: Top 18%
HER2/EGFR in Cancer Research
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.